Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Comparing Laringocel® and C‑MAC® video laryngoscopes for placing breathing tubes during elective surgery

Official title: Estimation of the Non-Inferiority of the Laringocel® Videolaryngoscope Compared With the C-MAC D-BLADE (Karl Storz®) for First-Attempt Intubation in Adult Patients Undergoing Elective Surgery

Run by Universidad de Antioquia · NCT07239141 · Data updated 2026-11-12

This comparison will test whether the Colombian Laringocel® video laryngoscope works as well as the C‑MAC D‑Blade® to help anesthesiologists place breathing tubes in adults having elective surgery.

More Airway Management trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment252 (estimated)
SponsorUniversidad de Antioquia
Academic / other
Locations1 site (Medellín, Antioquia)
StatusRecruiting
StartedDecember 4, 2025
Main results expectedApril 2026
Study endsApril 2026
Registry record updatedDecember 11, 2025
Trial IDNCT07239141 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 and older scheduled for elective surgery under general anesthesia who require single-lumen orotracheal intubation and meet standard preoperative fasting and anesthesia criteria.

Probably not a fit

Patients with an anticipated difficult airway (more than two anatomical risk factors) or those undergoing non-elective/emergency procedures are excluded and unlikely to benefit from this comparison.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, single-center trial will enroll 252 adults undergoing elective surgery at Hospital Alma Máter de Antioquia and assign them 1:1 to intubation with either Laringocel® or the C‑MAC D‑Blade®. Only trained anesthesiologists will perform orotracheal intubation using the assigned video laryngoscope. The primary outcome is first-attempt intubation success (first-pass rate), with procedural details and safety data recorded for each case. The goal is to determine whether the locally made Laringocel® performs similarly to the widely used C‑MAC device and could offer a lower-cost option.

Why it matters

Potential benefit: If Laringocel® performs similarly, it could offer hospitals a more affordable video laryngoscope option without sacrificing first-attempt intubation success.

How similar studies have gone: Video laryngoscopy is well established and many devices have improved first-pass intubation rates in prior trials, but direct randomized comparisons involving the Laringocel® are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients 18 years of age or older
* Patients scheduled for elective surgery under general anesthesia
* Patients requiring single-lumen orotracheal intubation
* Patients compliant with the anesthetic indication and standard preoperative fasting requirements

Exclusion Criteria:

* Patients with an anticipated difficult airway (more than two anatomical risk factors for difficult airway)
* Patient refusal to participate in the study via informed consent

Where it's running

  • Hospital Alma Máter de Antioquia
    Medellín, Antioquia, Colombia
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.